European Respiratory Society
Tracked across 7 events · 60 articles · First seen Jul 20, 2026 · Last active Sep 15, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Research presented at the European Respiratory Society Congress in Barcelona, Spain, found that patients with lung cancer are more likely to have microplastics in their lungs and in larger quantities than those without cancer. The…
Impact: Hosted the congress where the research was presented; its Advocacy Council chair commented on the findings.
Sep 03, 2026 · 8 articles
Tech
Research presented at the European Respiratory Society Congress in Barcelona, Spain, in September 2026 found that higher levels of two common bacteria, Streptomyces and Mycobacterium, in classroom dust are associated with reduced lung function in…
Impact: Hosted the congress where the research was presented, lending credibility and visibility to the findings.
Sep 06, 2026 · 6 articles
Tech
Research presented at the European Respiratory Society Congress in Barcelona found that popular AI chatbots often fail to maintain correct medical advice when patients resist referral. In a study led by Dr. Deeban Ratneswaran of…
Impact: Hosted the congress where the research was presented, lending scientific credibility to the findings.
Sep 06, 2026 · 6 articles
Tech
A real-world study led by Professor Chloe Bloom of the National Heart & Lung Institute at Imperial College London, and presented by Dr Bohee Lee, found that semaglutide, the active ingredient in Ozempic and Wegovy,…
Impact: Hosted the congress in Spain — Barcelona where the findings were presented, serving as the scientific platform for the study.
Sep 07, 2026 · 22 articles
Tech
A large observational study published in ERJ Open Research found that overuse of short-acting reliever inhalers among asthma and COPD patients is associated with higher risks of cardiovascular disease and death, including heart failure, heart…
Impact: Professional body whose expert group provided independent commentary, reinforcing the call for better monitoring of reliever inhaler overuse.
Aug 26, 2026 · 6 articles
Tech
AstraZeneca announced positive full results from the Phase III OBERON and TITANIA trials of tozorakimab, a first-in-class IL-33-targeting monoclonal antibody, in chronic obstructive pulmonary disease (COPD). Tozorakimab 300mg every four weeks reduced moderate and severe…
Impact: Venue for late-breaking presentation of the trial results at its 2026 Congress.
Sep 08, 2026 · 6 articles
Tech
Impact: Co-authored the 2022 guidelines that referenced PADN as an investigational therapy, providing context but not directly involved in this trial.
Jul 20, 2026 · 6 articles
60
AstraZeneca presented data European Respiratory SocietyAstraZeneca tozorakimab...
40
European Respiratory Society hosted congressSemaglutide Linked to 40%...
ERGEN INTELLIGENCE
Track European Respiratory Society live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard